Prime Medicine, Inc.
Cash Flow Statement
| Line Item | Sep 2023 | Jun 2023 | Mar 2023 | Sep 2022 | Jun 2022 | Mar 2022 | Sep 2021 | Jun 2021 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-50.7M | $-42.4M | $-39.4M | $-29.4M | $-29.3M | $-23.8M | $-16.4M | $616.0K |
| Depreciation & Amortization | $1.2M | $1.1M | $1.1M | $631.0K | $430.0K | $293.0K | $200.0K | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | $1.7M | — | — | $1.1M | — | — |
| Net Cash from Operating Activities | — | — | $-41.6M | — | — | $-50.8M | — | — |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | $2.0M | — | — | $1.7M | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $-12.7M | — | — | $30.9M | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $68.0K | — | — | $-1.3M | — | — |
| Net Change in Cash | — | — | $-54.2M | — | — | $-21.2M | — | — |
| Free Cash Flow | — | — | $-43.6M | — | — | $-52.5M | — | — |
Focus on wisdom, rationality, learning, and avoiding stupidity in life and investing.